MX2011006075A - Compuestos de fenazopiridina. - Google Patents

Compuestos de fenazopiridina.

Info

Publication number
MX2011006075A
MX2011006075A MX2011006075A MX2011006075A MX2011006075A MX 2011006075 A MX2011006075 A MX 2011006075A MX 2011006075 A MX2011006075 A MX 2011006075A MX 2011006075 A MX2011006075 A MX 2011006075A MX 2011006075 A MX2011006075 A MX 2011006075A
Authority
MX
Mexico
Prior art keywords
compounds
phenazopyridine
formula
present
phenazopyridines
Prior art date
Application number
MX2011006075A
Other languages
English (en)
Inventor
George Bonneville
Sidney Hecht
Nour Eddine Fahmi
Samir D Roy
Original Assignee
Pinnacle Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42269135&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011006075(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pinnacle Pharmaceuticals Inc filed Critical Pinnacle Pharmaceuticals Inc
Publication of MX2011006075A publication Critical patent/MX2011006075A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La presente invención está dirigida a fenazopiridinas sustituidas representadas por la fórmula I. (ver fórmula (I)) La presente invención se refiere también al descubrimiento de que los compuestos de la fórmula I tienen biodisponibilidad incrementada en comparación con fenazopiridina no conjugada.
MX2011006075A 2008-12-19 2009-12-21 Compuestos de fenazopiridina. MX2011006075A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13942808P 2008-12-19 2008-12-19
US23266309P 2009-08-10 2009-08-10
PCT/US2009/068963 WO2010071878A1 (en) 2008-12-19 2009-12-21 Phenazopyridine compounds

Publications (1)

Publication Number Publication Date
MX2011006075A true MX2011006075A (es) 2011-09-27

Family

ID=42269135

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011006075A MX2011006075A (es) 2008-12-19 2009-12-21 Compuestos de fenazopiridina.

Country Status (14)

Country Link
US (3) US7893042B2 (es)
EP (1) EP2367426A4 (es)
JP (1) JP2012512914A (es)
KR (1) KR20110082601A (es)
CN (1) CN102256486A (es)
AU (1) AU2009327322A1 (es)
BR (1) BRPI0923114A2 (es)
CA (1) CA2747716A1 (es)
CL (1) CL2011001515A1 (es)
EA (1) EA201170606A1 (es)
IL (1) IL213062A0 (es)
MX (1) MX2011006075A (es)
WO (1) WO2010071878A1 (es)
ZA (1) ZA201103724B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012512914A (ja) 2008-12-19 2012-06-07 ピナクル ファーマシューティカルズ インコーポレイテッド フェナゾピリジン化合物
AU2016302697B2 (en) * 2015-08-06 2020-10-29 F. Hoffmann-La Roche Ag Processes for the preparation of GalNAc acid derivatives
US11549888B2 (en) * 2019-10-03 2023-01-10 Hach Company Method for measuring monochloramine in seawater
JP2024508804A (ja) * 2021-02-24 2024-02-28 カシーヴ バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー アゾ化合物及びその塩のプロドラッグ

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024A (en) * 1845-05-01 Cutting and crushing corn-fodder
US2135293A (en) * 1936-08-20 1938-11-01 Pyridium Corp Medicinal azo dyes
US3493555A (en) 1966-03-23 1970-02-03 Nepera Chem Co Inc 3-phenylazo-2,6-pyridyl dicyclopropane-carboxamide
DE2251719A1 (de) 1972-10-21 1974-04-25 Basf Ag 6700 Ludwigshafen Dispersionsfarbstoffe der 2,6diaminopyridinreihe
USRE29640E (en) 1970-12-19 1978-05-23 Basf Aktiengesellschaft Certain substituted 2,6-diamino-4-methyl-nicotinitriles the corresponding nicotinamides and derivatives thereof
US4829070A (en) * 1982-05-18 1989-05-09 University Of Florida Novel redox carriers for brain-specific drug delivery
JPH01193375A (ja) 1988-01-29 1989-08-03 Canon Inc 記録液
JPH0667467A (ja) 1992-08-25 1994-03-11 Mitsui Toatsu Chem Inc 後染色型カラートナー用色素及びカラートナー
IT1256111B (it) * 1992-11-23 1995-11-28 Lifegroup Spa Sali dell'acido traumatico ad attivita' cicatrizzante ed antibatterica
US7018654B2 (en) 1999-03-05 2006-03-28 New River Pharmaceuticals Inc. Pharmaceutical composition containing an active agent in an amino acid copolymer structure
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US20040248963A1 (en) * 2001-11-23 2004-12-09 Bueno Melendo Ana Belen Prodrugs of excitatory amino acids
JP2004059687A (ja) 2002-07-26 2004-02-26 Fuji Photo Film Co Ltd 着色組成物、インクジェット記録用インク、インクジェット記録方法、感熱記録材料、カラートナー、およびカラーフィルター
US8173840B2 (en) 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
SG145693A1 (en) * 2003-07-29 2008-09-29 Signature R & D Holdings Llc Amino acid prodrugs
US7589233B2 (en) 2003-07-29 2009-09-15 Signature R&D Holdings, Llc L-Threonine derivatives of high therapeutic index
WO2006114324A1 (en) * 2005-04-28 2006-11-02 Schering Ag Compounds comprising cyclized somatostatin receptor binding peptides
WO2007041677A2 (en) * 2005-10-03 2007-04-12 Combinatorx, Incorporated Soft tissue implants and drug combination compositions, and use thereof
GB0521549D0 (en) 2005-10-22 2005-11-30 Avecia Inkjet Ltd Yellow azo dyes for ink jet printing
JP2012512914A (ja) 2008-12-19 2012-06-07 ピナクル ファーマシューティカルズ インコーポレイテッド フェナゾピリジン化合物

Also Published As

Publication number Publication date
US20100204185A1 (en) 2010-08-12
EA201170606A1 (ru) 2011-12-30
CN102256486A (zh) 2011-11-23
AU2009327322A1 (en) 2011-06-30
US8288365B2 (en) 2012-10-16
ZA201103724B (en) 2012-09-26
BRPI0923114A2 (pt) 2015-08-11
EP2367426A1 (en) 2011-09-28
US20130040917A1 (en) 2013-02-14
JP2012512914A (ja) 2012-06-07
US20110319367A1 (en) 2011-12-29
EP2367426A4 (en) 2012-05-02
CL2011001515A1 (es) 2012-07-20
KR20110082601A (ko) 2011-07-19
IL213062A0 (en) 2011-07-31
WO2010071878A1 (en) 2010-06-24
CA2747716A1 (en) 2010-06-24
US7893042B2 (en) 2011-02-22

Similar Documents

Publication Publication Date Title
IN2012DN02751A (es)
MX350892B (es) Síntesis de compuesto antiviral.
GEP20156266B (en) Spiroheterocyclic n-oxypiperidines as pesticides
AU2011232516A8 (en) Chemical compounds
MX2013002461A (es) Compuestos y composiciones novedosos para la inhibición de nampt.
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
CR20120297A (es) Espironucleósidos uracílicos oxetánicos
MX2009007695A (es) Compuestos complejos de carbohidrato de hierro.
MY164776A (en) Heterocyclic compound
EA201590979A1 (ru) Способы и промежуточные химические соединения для получения фармацевтических средств
UY32481A (es) Derivados de benzofurano
EA200900945A1 (ru) Новый способ синтеза агомелатина
IN2013MN02014A (es)
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
EA201101675A1 (ru) Спироэпоксиды как промежуточные продукты синтеза
IN2014MN01521A (es)
EA200900946A1 (ru) Новый способ синтеза агомелатина
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
EA201270255A1 (ru) 5-фтор-2-оксопиримидин-1(2h)-карбоксилатные производные
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
EA201200820A1 (ru) Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
EA200801549A1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина
MX2012007835A (es) Derivados de oxazolopirimidina sustituida en 2, 5,7.
EA201170721A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов рецептора хемокина

Legal Events

Date Code Title Description
FG Grant or registration